Morningstar US Small Growth Rating $13.91 0.00 (0.00%) As of 06/12/2026 Add Compare Share Share Ratings Stock AnalysisChartRatingsBuy This Stock Morningstar US Small Growth Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MSGR Aggregate RatingHold 2.34Holdings in MSGR have an aggregate rating of Hold based on 271 analyst ratings issued in the past year covering 20 companies (89.3% of the portfolio).MSGR Aggregate Price Target$13.91High Prediction$13.91Average Prediction$13.91Low Prediction$13.91Holdings in MSGR have an aggregate price target of $13.91 and a range of $13.91 to $13.91 covering 20 companies (89.3% of the portfolio).MSGR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce3 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Morningstar US Small Growth Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 20 MSGR Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.06%VRTXVertex Pharmaceuticals$448.17+0.7%4.6443 of 5 stars2.88$555.91 24.0%25Positive News7.99%SCLXScilex$8.45-0.6%0.4071 of 5 stars1.0017.01%ARCTArcturus Therapeutics$7.25+3.9%2.9064 of 5 stars2.67$25.44 251.2%12Positive NewsGap Up6.62%ALNYAlnylam Pharmaceuticals$283.51+0.2%4.6368 of 5 stars2.85$463.13 63.4%26Positive NewsAnalyst UpgradeGap Up6.44%MRNAModerna$50.11+0.4%1.3316 of 5 stars1.83$36.60 -27.0%186.17%BNTXBioNTech$91.51+1.1%4.5734 of 5 stars2.74$129.56 41.6%19Positive News5.97%SRPTSarepta Therapeutics$15.82+3.4%3.4631 of 5 stars2.07$24.77 56.6%27Positive NewsGap Up5.78%PTCTPTC Therapeutics$72.08-4.1%3.3338 of 5 stars2.71$91.36 26.7%14Positive NewsInsider TradeGap Down4.94%MRVIMaravai LifeSciences$4.95-0.7%2.9136 of 5 stars2.20$5.50 11.2%54.29%NTLAIntellia Therapeutics$13.47+11.2%3.1959 of 5 stars2.35$20.46 51.9%23News CoverageAnalyst ForecastGap Up4.24%IONSIonis Pharmaceuticals$73.44+0.2%3.6249 of 5 stars2.90$100.90 37.4%21Positive News3.19%CVACCureVac$4.66N/A1.50$5.50 18.0%23.19%RNAAvidity Biosciences$12.49+1.0%2.409 of 5 stars2.33$70.29 462.8%18News CoveragePositive News3.18%ARWRArrowhead Pharmaceuticals$76.23+2.3%2.8023 of 5 stars2.75$87.80 15.2%12Positive News2.95%ABUSArbutus Biopharma$4.29+0.6%1.8332 of 5 stars2.00$5.00 16.6%22.59%DYNDyne Therapeutics$18.45+1.5%3.0728 of 5 stars2.94$35.00 89.7%17Positive News2.10%SGMOSangamo Therapeutics$0.17+9.6%1.1544 of 5 stars1.75$5.50 3,223.3%41.84%STOKStoke Therapeutics$29.46-1.2%3.4572 of 5 stars2.73$41.83 42.0%11News Coverage1.52%PRQRProQR Therapeutics$1.45+0.3%3.1013 of 5 stars2.63$7.25 401.7%8News CoveragePositive News1.20%PEPGPepGen$1.51+2.4%2.6561 of 5 stars2.67$11.60 670.8%6Gap Up This page (NYSEARCA:MSGR) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morningstar US Small Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share Morningstar US Small Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MSGR Stock Alerts